AKT1 and neoplasm: Recently, miR-19a was identified as a key molecule responsible for the oncogenic activity of the cluster, and was shown to reduce the tumor suppressor PTEN level, and consequently activate the AKT/mTOR (mammalian target of rapamycin) pathway [37], [38].